triiodothyronine has been researched along with Menopause in 46 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aminoglutethimide is effective in the treatment of breast cancer in postmenopausal patients as a result of its inhibition of aromatase." | 7.68 | Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. ( Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A, 1991) |
| "Conventional risk factors for NAFLD were assessed as well as serum levels of TSH, FT3 and FT4." | 5.42 | Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects. ( Guan, L; Guan, Q; Jiang, Q; Jiang, Z; Lin, H; Liu, G; Yu, C; Zhang, N; Zhang, X; Zhang, Y; Zheng, X, 2015) |
| "In a randomized, controlled study, 59 euthyroid women with surgical menopause were randomized to an estrogen-only (n=20), tibolone (n=20) or calcium-only (n=19) group." | 5.12 | Effect of different hormonal therapies on thyroid function in surgical menopause: short-term results. ( Erel, CT; Gezer, A; Kaleli, S; Sentürk, LM; Seyisoglu, H; Somunkiran, A, 2007) |
| " The aim of this study was analysis of cognitive function levels in reference to thyroid examination: thyroid-stimulating hormone (TSH), total thyroxin (TT4), triiodothyronine (TT3), free thyroxin (FT4), free triiodothyronine (FT3), thyroperoxidase antibodies (TPO-AB), and thyroglobulin antibodies (Tg-AB), TSH receptor antibodies (AB-TSHR) in women after menopause." | 3.81 | Functional status of thyroid and cognitive functions after menopause. ( Bojar, I; Gnatowski, M; Gujski, M; Owoc, A; Walecka, I; Witczak, M, 2015) |
| " We assessed the subjects according to the Simplified Menopause Index, menstrual status, thyroid hormone measurements (thyroid stimulating hormone, free thyroxine, free triiodothyronine), the presence of Hashimoto's disease antibodies (anti-thyroid peroxidase antibody or anti-thyroglobulin antibody), the presence of Grave's disease (anti-TSH receptor antibody), markers of thyroid tumor (high thyroglobulin), and thyroid ultrasonography studies." | 3.79 | Comparison of the symptoms of menopause and symptoms of thyroid disease in Japanese women aged 35-59 years. ( Ohi, K; Oi, N, 2013) |
| "Aminoglutethimide is effective in the treatment of breast cancer in postmenopausal patients as a result of its inhibition of aromatase." | 3.68 | Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. ( Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A, 1991) |
| "In breast cancer a decrease in triiodothyronine concentration was revealed with the normal level of thyroxine that may be associated with the disturbed peripheral metabolism into triiodothyronine." | 3.67 | [Thyroid and hypophyseal function during radiation therapy of breast cancer]. ( Iakimova, TP; Lozinskaia, IN, 1984) |
| "Serum tri-iodothyronine (T3), thyroxine (T4) and thyroid-stimulating hormone (TSH) concentrations were measured in 50 postmenopausal patients with breast cancer receiving tamoxifen therapy." | 3.67 | The effect of tamoxifen therapy on thyroid function tests. ( Beastall, GH; Gordon, D; McArdle, CS; Thomson, JA, 1986) |
| "Levels of circulating estrone (E1), estradiol (E2), androst-4-ene-3,17-dione (Adione), 3,5,3'-triiodothyronine (T3), thyroxine (T4), and sex hormone-binding globulin (SHBG) were measured in 10 obese postmenopausal patients with breast cancer and in 10 obese postmenopausal control subjects matched for age, body size, and menopausal status." | 3.67 | Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss. ( Cardillo, LR; del Carmen Cremona, M; Enriori, CL; Etkin, AE; Orsini, W; Reforzo-Membrives, J, 1986) |
| "Serum levels of thyroid-stimulating hormone (TSH), triiodothyronine (T3), thyroxine (T4), free triidotthyronine (FT3), free thyroxine (FT4) and thyroxine-binding globulin (TBG) were measured in 382 healthy women who were attending a menopause clinic." | 3.66 | A study of thyroid function in the pre- and post-menopause. ( Bottiglioni, F; Capelli, M; de Aloysio, D; Mantuano, R; Mauloni, M; Nicoletti, G, 1983) |
| "Triiodothyronine (T3) was administered to the two groups as 20 micrograms doses three times daily for 7 days." | 2.68 | Skeletal responsiveness to thyroid hormone is not altered at menopause. ( Charles, P; Eriksen, EF; Langdahl, BL; Loft, AG; Mosekilde, L; Møller, N; Weeke, J, 1996) |
| "Conventional risk factors for NAFLD were assessed as well as serum levels of TSH, FT3 and FT4." | 1.42 | Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects. ( Guan, L; Guan, Q; Jiang, Q; Jiang, Z; Lin, H; Liu, G; Yu, C; Zhang, N; Zhang, X; Zhang, Y; Zheng, X, 2015) |
| "The prevalence of hypothyroidism has been reported to increase with age and to attain up to 10% in older women." | 1.29 | Screening for thyroid disease at the menopausal clinic. ( Bissonnette, F; Brossard, JH; D'Amour, P; Faughnan, M; Fugère, P; Lepage, R, 1995) |
| "In 20 patients with primary hypothyroidism mean serum hTSH-beta was 1." | 1.25 | Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders. ( Kourides, IA; Maloof, F; Ridgway, EC; Weintraub, BD, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (58.70) | 18.7374 |
| 1990's | 11 (23.91) | 18.2507 |
| 2000's | 4 (8.70) | 29.6817 |
| 2010's | 3 (6.52) | 24.3611 |
| 2020's | 1 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| Slopien, R | 1 |
| Owecki, M | 1 |
| Slopien, A | 1 |
| Bala, G | 1 |
| Meczekalski, B | 1 |
| Liu, G | 1 |
| Zheng, X | 1 |
| Guan, L | 1 |
| Jiang, Z | 1 |
| Lin, H | 1 |
| Jiang, Q | 1 |
| Zhang, N | 1 |
| Zhang, Y | 1 |
| Zhang, X | 1 |
| Yu, C | 1 |
| Guan, Q | 1 |
| Bojar, I | 1 |
| Owoc, A | 1 |
| Gujski, M | 1 |
| Witczak, M | 1 |
| Gnatowski, M | 1 |
| Walecka, I | 1 |
| Oi, N | 1 |
| Ohi, K | 1 |
| Loviselli, A | 1 |
| Rizzolo, E | 1 |
| Mastinu, R | 1 |
| Velluzzi, F | 1 |
| Secci, G | 1 |
| Taberlet, A | 1 |
| Mariotti, S | 1 |
| SASSI, D | 1 |
| Erel, CT | 1 |
| Gezer, A | 1 |
| Sentürk, LM | 1 |
| Somunkiran, A | 1 |
| Kaleli, S | 1 |
| Seyisoglu, H | 1 |
| Rosselin, G | 1 |
| Dolais, J | 1 |
| Iakimova, TP | 1 |
| Lozinskaia, IN | 1 |
| Bottiglioni, F | 1 |
| de Aloysio, D | 1 |
| Nicoletti, G | 1 |
| Mauloni, M | 1 |
| Mantuano, R | 1 |
| Capelli, M | 1 |
| Abdalla, HI | 1 |
| Hart, DM | 1 |
| Beastall, GH | 2 |
| Balan, VE | 1 |
| Gordon, M | 1 |
| Gryfe, CI | 1 |
| Faughnan, M | 1 |
| Lepage, R | 1 |
| Fugère, P | 1 |
| Bissonnette, F | 1 |
| Brossard, JH | 1 |
| D'Amour, P | 1 |
| Dryzhak, VI | 1 |
| Pepper, GM | 1 |
| Koenigsberg, R | 1 |
| Zito, JL | 1 |
| Deutsch, S | 1 |
| Földes, J | 1 |
| Tarján, G | 1 |
| Szathmari, M | 1 |
| Varga, F | 1 |
| Krasznai, I | 1 |
| Horvath, C | 1 |
| Langdahl, BL | 1 |
| Loft, AG | 1 |
| Møller, N | 1 |
| Weeke, J | 1 |
| Eriksen, EF | 1 |
| Mosekilde, L | 1 |
| Charles, P | 1 |
| Bellipanni, G | 1 |
| Bianchi, P | 1 |
| Pierpaoli, W | 1 |
| Bulian, D | 1 |
| Ilyia, E | 1 |
| Lindblom, P | 1 |
| Valdemarsson, S | 1 |
| Lindergård, B | 1 |
| Westerdahl, J | 1 |
| Bergenfelz, A | 1 |
| Smallridge, RC | 1 |
| Wartofsky, L | 2 |
| Dimond, RC | 2 |
| Medeiros-Neto, GA | 1 |
| Knobel, M | 1 |
| Barros, A | 1 |
| de Ulhoa Cintra, AB | 1 |
| Rutlin, E | 1 |
| Haug, E | 1 |
| Torjesen, PA | 1 |
| Hall, R | 1 |
| Gomez-Pan, A | 1 |
| Kourides, IA | 1 |
| Weintraub, BD | 1 |
| Ridgway, EC | 1 |
| Maloof, F | 1 |
| Rossmanith, WG | 2 |
| Stäbler, C | 1 |
| Benz, R | 1 |
| Bornstein, SR | 1 |
| Scherbaum, WA | 2 |
| Astrup, A | 1 |
| Buemann, B | 1 |
| Christensen, NJ | 1 |
| Madsen, J | 1 |
| Gluud, C | 1 |
| Bennett, P | 1 |
| Svenstrup, B | 1 |
| Szilagyi, A | 1 |
| Dowsett, M | 1 |
| Mehta, A | 1 |
| Cantwell, BM | 1 |
| Harris, AL | 1 |
| Schoutens, A | 1 |
| Laurent, E | 1 |
| Markowicz, E | 1 |
| Lisart, J | 1 |
| De Maertelaer, V | 1 |
| Adlin, EV | 1 |
| Maurer, AH | 1 |
| Marks, AD | 1 |
| Channick, BJ | 1 |
| Takatani, O | 1 |
| Okumoto, T | 1 |
| Kosano, H | 1 |
| Nishida, M | 1 |
| Hiraide, H | 1 |
| Tamakuma, S | 1 |
| Custro, N | 1 |
| Scafidi, V | 1 |
| Rachev, E | 1 |
| Zakharieva, B | 1 |
| Vasilev, D | 1 |
| Gordon, D | 1 |
| McArdle, CS | 1 |
| Thomson, JA | 1 |
| Quint, AR | 1 |
| Kaiser, FE | 1 |
| Dogliotti, L | 1 |
| Faggiuolo, R | 1 |
| Ferusso, A | 1 |
| Orlandi, F | 1 |
| Sandrucci, S | 1 |
| Tibo, A | 1 |
| Angeli, A | 1 |
| Enriori, CL | 1 |
| Orsini, W | 1 |
| del Carmen Cremona, M | 1 |
| Etkin, AE | 1 |
| Cardillo, LR | 1 |
| Reforzo-Membrives, J | 1 |
| Gardner, B | 1 |
| Kolendorf, K | 1 |
| Siersbaek-Nielsen, K | 1 |
| Hansen, MJ | 1 |
| Friis, T | 1 |
| Tamaoka, T | 1 |
| Heath, H | 1 |
| Lee, RB | 1 |
| Williams, DC | 1 |
| Wheatley, D | 1 |
| Tulchinsky, D | 1 |
| Chopra, IJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Predicting Adaptive Thermogenesis[NCT00687115] | Phase 2 | 83 participants (Actual) | Interventional | 2008-09-18 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for triiodothyronine and Menopause
| Article | Year |
|---|---|
The hypothalamic regulatory hormones and their clinical applications.
Topics: Female; Follicle Stimulating Hormone; Gastrins; Glucagon; Gonadotropin-Releasing Hormone; Humans; Hy | 1976 |
Steroid hormones and breast cancer.
Topics: Adrenal Cortex; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Age Factors; Binding Sit | 1974 |
5 trials available for triiodothyronine and Menopause
| Article | Year |
|---|---|
Effect of different hormonal therapies on thyroid function in surgical menopause: short-term results.
Topics: Adult; Calcium; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Co | 2007 |
Reduced serum free thyroxine concentration in postmenopausal women receiving oestrogen treatment.
Topics: Female; Humans; Menopause; Mestranol; Middle Aged; Thyrotropin; Thyroxine; Thyroxine-Binding Protein | 1984 |
Skeletal responsiveness to thyroid hormone is not altered at menopause.
Topics: Alkaline Phosphatase; Amino Acids; Blood Chemical Analysis; Blood Gas Analysis; Bone Density; Bone R | 1996 |
Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study.
Topics: Adult; Affect; Circadian Rhythm; Depression; Double-Blind Method; Female; Follicle Stimulating Hormo | 2001 |
Evaluation of psychotropic drugs in general practice.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Depressio | 1972 |
39 other studies available for triiodothyronine and Menopause
| Article | Year |
|---|---|
Climacteric symptoms are related to thyroid status in euthyroid menopausal women.
Topics: Adult; Aged; Biomarkers; Climacteric; Female; Follow-Up Studies; Humans; Menopause; Middle Aged; Pro | 2020 |
Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects.
Topics: Adult; China; Comorbidity; Female; Humans; Male; Menopause; Metabolic Syndrome; Middle Aged; Non-alc | 2015 |
Functional status of thyroid and cognitive functions after menopause.
Topics: Analysis of Variance; Attention; Cognition; Executive Function; Female; Humans; Menopause; Middle Ag | 2015 |
Comparison of the symptoms of menopause and symptoms of thyroid disease in Japanese women aged 35-59 years.
Topics: Adult; Arrhythmias, Cardiac; Autoantibodies; Diagnosis, Differential; Female; Flushing; Graves Disea | 2013 |
High serum circulating telopeptide type I in multinodular goiter.
Topics: Adult; Aged; Biomarkers; Collagen Type I; Female; Goiter, Nodular; Humans; Hyperthyroidism; Menopaus | 2003 |
[On the Watson syndrome in the preclimacteric and climacteric age].
Topics: Climacteric; Female; Humans; Hypothyroidism; Menopause; Neurofibromatosis 1; Premenopause; Triiodoth | 1962 |
[Determination of the human follicle-stimulating hormone (H.F.S.H.) by the radio-immunological method. Preliminary results obtained in the normal and hypogonadal male; in the female during the menstrual cycle and after the menopause. Effect of various pit
Topics: Adult; Aged; Chorionic Gonadotropin; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans | 1967 |
[Thyroid and hypophyseal function during radiation therapy of breast cancer].
Topics: Adult; Breast Neoplasms; Female; Growth Hormone; Humans; Insulin; Menopause; Middle Aged; Pituitary | 1984 |
A study of thyroid function in the pre- and post-menopause.
Topics: Adult; Aging; Climacteric; Female; Humans; Menopause; Middle Aged; Thyroid Gland; Thyrotropin; Thyro | 1983 |
[Function of the thyrotropic-thyroid system in physiological and pathological climacteric].
Topics: Adult; Climacteric; Female; Humans; Menopause; Menstruation; Middle Aged; Pituitary Gland, Anterior; | 1983 |
Hyperthyroidism with painless subacute thyroiditis in the elderly.
Topics: Age Factors; Aged; Female; Humans; Hyperthyroidism; Menopause; Middle Aged; Pain; Syndrome; Thyroidi | 1981 |
Screening for thyroid disease at the menopausal clinic.
Topics: Ambulatory Care Facilities; Autoantibodies; Biomarkers; Female; Humans; Hypothyroidism; Mass Screeni | 1995 |
[Thyroid function in breast cancer patients].
Topics: Adult; Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Radioimmunoassay; Thyroid Gland; Th | 1993 |
Alteration of serum pituitary hormone levels in postmenopausal women with stroke.
Topics: Aged; Aged, 80 and over; Cerebrovascular Disorders; Estradiol; Female; Follicle Stimulating Hormone; | 1993 |
Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?
Topics: Adult; Aged; Bone Density; Cross-Sectional Studies; Female; Femur Neck; Goiter, Nodular; Humans; Hyp | 1993 |
Decreased levels of ionized calcium one year after hemithyroidectomy: importance of reduced thyroid hormones.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Calcitriol; Calcium; Collagen; Collagen Type I; Female | 2001 |
Inappropriate secretion of thyrotropin: discordance between the suppressive effects of corticosteroids and thyroid hormone.
Topics: Acromegaly; Female; Growth Hormone; Humans; Hyperthyroidism; Menopause; Methimazole; Middle Aged; Pr | 1979 |
[Pituitary response to synthetic LH-RH stimulus in patients with hypothyroidism, before and after treatment with thyroxine and triiodothyronine].
Topics: Adolescent; Adult; Female; Gonadotropin-Releasing Hormone; Humans; Hypothalamus; Hypothyroidism; Mal | 1978 |
Serum thyrotrophin, prolactin and growth hormone, response to TRH during oestrogen treatment.
Topics: Adult; Aged; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Lut | 1977 |
Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders.
Topics: Adult; Age Factors; Aged; Apoproteins; Female; Follicle Stimulating Hormone; Humans; Hypothyroidism; | 1975 |
Role of ovarian sex steroids in the regulation of thyrotropin (TSH) secretion of hypogonadal women.
Topics: Administration, Oral; Estradiol; Female; Humans; Hypogonadism; Menopause; Middle Aged; Progesterone; | 1992 |
The contribution of body composition, substrates, and hormones to the variability in energy expenditure and substrate utilization in premenopausal women.
Topics: Adolescent; Adult; Blood Glucose; Body Composition; C-Peptide; Calorimetry; Dehydroepiandrosterone; | 1992 |
Episodic thyrotropin (TSH) and prolactin (PRL) secretion during aging in postmenopausal women.
Topics: Aged; Aged, 80 and over; Aging; Female; Humans; Menopause; Middle Aged; Periodicity; Prolactin; Thyr | 1992 |
Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aminoglutethimide; Androstenedione; Breas | 1991 |
Serum triiodothyronine, bone turnover, and bone mass changes in euthyroid pre- and postmenopausal women.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Bone Density; Estradiol; Estrogens; Female; Humans; Hyd | 1991 |
Bone mineral density in postmenopausal women treated with L-thyroxine.
Topics: Aged; Bone Density; Calcitonin; Female; Femur Neck; Humans; Hyperthyroidism; Lumbar Vertebrae; Menop | 1991 |
Relationship between the levels of serum thyroid hormones or estrogen status and the risk of breast cancer genesis in Japanese women.
Topics: Adult; Breast Neoplasms; Estradiol; Female; Humans; Japan; Menopause; Middle Aged; Random Allocation | 1989 |
Mild hyperthyroidism with inappropriate secretion of TSH in postmenopausal women.
Topics: Female; Humans; Hyperthyroidism; Hypothalamo-Hypophyseal System; Menopause; Middle Aged; Thyroid Gla | 1986 |
[Thyrotropic-thyroid function in women with uterine hemorrhages in the premenopause].
Topics: Adult; Climacteric; Female; Humans; Menopause; Middle Aged; Thyroid Gland; Thyrotropin; Thyroxine; T | 1988 |
The effect of tamoxifen therapy on thyroid function tests.
Topics: Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Tamoxifen; Thyroid Function Tests; Thyroid | 1986 |
Gonadotropin determinations and thyrotropin-releasing hormone and luteinizing hormone-releasing hormone testing in critically ill postmenopausal women with hypothyroxinemia.
Topics: Adult; Aged; Critical Care; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Go | 1985 |
Prolactin and thyrotropin response to thyrotropin-releasing hormone in premenopausal women with fibrocystic disease of the breast.
Topics: Adult; Estradiol; Female; Fibrocystic Breast Disease; Humans; Kinetics; Menopause; Middle Aged; Prol | 1985 |
Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss.
Topics: Aged; Androstenedione; Body Weight; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Hydrocorti | 1986 |
Current concepts in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Adult; Androgens; Breast Neoplasms; Castration; Estrogens; Female; Fluorouracil; Huma | 1972 |
Letter: Replacement treatment of hypothyroidism.
Topics: Female; Humans; Hyperthyroidism; Hypothyroidism; Menopause; Osteoporosis; Thyroid Hormones; Thyrotro | 1974 |
Evaluation of thyroid status with "effective thyroxine ratio" (E.T.R.).
Topics: Adolescent; Adult; Aged; Aspirin; Depression, Chemical; Estrogens; Evaluation Studies as Topic; Fema | 1974 |
[Urinary gonadotropin in gynecology with special reference to adrenocortical function].
Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aged; Animals; Castration; Clomip | 1966 |
Conjugated estrogen therapy and tests of thyroid function.
Topics: Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Female; Humans; Menopause; Protein Bi | 1974 |
Competitive ligand-binding assay for measurement of sex hormone-binding globulin (SHBG).
Topics: Adult; Aged; Binding, Competitive; Dihydrotestosterone; Estradiol; Female; Hirsutism; Humans; Hypert | 1973 |